New IOL tech | 合法醫療器材資訊網

由 DR Sanders 著作 · 2010 · 被引用 33 次 — 723. Journal of Refractive Surgery • Vol. 26, No. 10, 2010. US FDA Clinical Trial of the Tetraflex. Potentially Accommodating IOL: Comparison to Concurrent Age-​ ... Read More

由 PJ DOUGHERTY 著作 · 被引用 5 次 — The Tetraflex IOL is currently in phase 3 FDA clinical trials in seven centers in ... lens, when and if approved by the FDA, will be the presbyopic IOL of choice. □. Read More

The Tetraflex IOL is currently in phase 3 FDA clinical trials in seven centers in the ... lens, when and if approved by the FDA, will be the presbyopic IOL of choice. Read More

Another accommodating IOL in the FDA approval pipeline is the Tetraflex (​Lenstec, Inc., St. Petersburg, FL). Like the Crystalens (Bausch & Lomb, Rochester​, ... Read More

2016年7月15日 — The U.S. Food and Drug Administration today approved the first intraocular lens (​IOL) that provides cataract patients with an extended ... Read More

2020年10月23日 — A range of new technology intraocular lenses addressing everything from ... Approved by the FDA in February, Vivity is available in Europe and launches ... and refractive power of the lens in response to accommodative effort. Read More

Multifocal and accommodative IOLs and the FDA approval process. ... While hundreds of monofocal intraocular lenses (IOLs) are on the U.S. market, only 10 of ... Read More

Read More

The Tetraflex FDA clinical trial has been truncated, and the company ... With the push toward refractive cataract surgery, presbyopia-correcting IOLs are steadily ... The FDA approval for the Crystalens described 1.00 D of accommodation, and I ... Read More

2015年9月5日 — Crystalens® and Trulign® Toric (both by Bausch + Lomb) are currently the only FDA-approved IOLs that can be described as accommodating. Read More